Status:
UNKNOWN
Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung Cancer
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Lung Cancer
Malignant Airway Obstruction
Eligibility:
All Genders
18-80 years
Brief Summary
Narrow-Band Imaging (NBI) is useful to better demarcate the superficial extent of central type of lung cancer, but its sensitivity and specificity in clinical practice were little studied. This study ...
Detailed Description
With high morbidity and mortality, lung cancer is one of the most common tumors in the world. Therefore, early detection, accurate diagnosis and staging division can effectively guide clinical interve...
Eligibility Criteria
Inclusion
- \- Patients had a history or current central lung cancer
Exclusion
- \- NONE
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04676815
Start Date
June 1 2023
End Date
July 1 2024
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Pulmonary Hospital
Shanghai, China, 200433